Montpellier, France

Gwenael Cheve

This inventor holds 2 USPTO granted patents. Top assignees: Institut Regional Du Cancer De Montpellier-Val D'aurelle, National Institute of Health and Medical Research, Oribase Pharma. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gwenael Cheve. Retrieved from https://idiyas.com/inventor/gwenael-cheve

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: A Glimpse into the Innovations of Inventor Gwenael Cheve

Introduction: Gwenael Cheve, an accomplished inventor based in Montpellier, France, has made significant contributions to the fields of diagnostic and therapeutic methods through his innovative work. With two patents to his name, Cheve continues to push the boundaries of medical research with his pioneering ideas and inventions.

Latest Patents: Gwenael Cheve's most recent patents focus on anti-Axl antibodies used in diagnostic and therapeutic applications. His invention details a monoclonal antibody that exhibits specificity for Axl, featuring a heavy chain variable region with designated sequences in the H-CDR1, H-CDR2, and H-CDR3 regions. Similarly, the light chain variable region is characterized by specific sequences in the L-CDR1, L-CDR2, and L-CDR3 regions. This monoclonal antibody is engineered to bind to the extracellular domain of Axl, providing valuable insights into potential treatment methods.

Career Highlights: Throughout his career, Gwenael Cheve has worked with prominent research institutions and companies, including Inserm and the Institut National de la Santé et de la Recherche Médicale. Additionally, he has made substantial contributions while working at Oribase Pharma, further demonstrating his commitment to advancing medical innovation.

Collaborations: In his journey as an inventor, Cheve has collaborated with notable individuals such as Bruno Robert and Benedicte Fauvel. These partnerships have fostered a rich exchange of ideas and expertise, enhancing the scope and impact of his inventions.

Conclusion: Gwenael Cheve is a testament to the power of innovation in medicine. His work with anti-Axl antibodies showcases not only his ingenuity but also his dedication to improving diagnostic and therapeutic methods. With a bright future ahead, Cheve's contributions will undoubtedly continue to shape the landscape of medical research and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…